Patents by Inventor TORBEN FALCK ØRNTOFT

TORBEN FALCK ØRNTOFT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for prostate cancer
    Patent number: 10106854
    Abstract: The present application concerns methods and tools for diagnosing prostate cancer and furthermore concerns methods and tools for prognosing disease progression of prostate cancer. The method comprises determining methylation level of the genes C1orf114, HAPLN3, AOX1, GAS6, ST6GALNAC3 and ZNF660 and comparing the result with a control, thus obtaining a response which is used for diagnosing a prostate cancer and/or for prognosing aspects of an individual suffering from prostate cancer.
    Type: Grant
    Filed: June 14, 2013
    Date of Patent: October 23, 2018
    Assignees: Aarhus Universitet, Region Midtjylland
    Inventors: Torben Falck Ørntoft, Karina Dalsgaard Sørensen, Christa Haldrup
  • BIOMARKERS FOR PROSTATE CANCER
    Publication number: 20150152507
    Abstract: The present application concerns methods and tools for diagnosing prostate cancer and furthermore concerns methods and tools for prognosing disease progression of prostate cancer. The method comprises determining methylation level of the genes C1orf114, HAPLN3, AOX1, GAS6, ST6GALNAC3 and ZNF660 and comparing the result with a control, thus obtaining a response which is used for diagnosing a prostate cancer and/or for prognosing aspects of an individual suffering from prostate cancer.
    Type: Application
    Filed: June 14, 2013
    Publication date: June 4, 2015
    Inventors: Torben Falck Ørntoft, Karina Dalsgaard Sørensen, Christa Haldrup
  • Urinary Methylation Markers for Bladder Cancer
    Publication number: 20130041047
    Abstract: A method of detecting bladder cancer is described using hypermethylated urinary markers.
    Type: Application
    Filed: June 1, 2012
    Publication date: February 14, 2013
    Applicant: AROS APPLIED BIOTECHNOLOGY AS
    Inventors: Torben Falck Ørntoft, Lars Dyrskjøt Andersen, Jørgen Thomas Reinert, Charlotte Modin, Philippe Lamy
  • MARKER OF PROSTATE CANCER
    Publication number: 20100303795
    Abstract: An SLC18A2 gene serves as a marker of prostate cancer. Methods are provided for diagnosing prostate cancer, predicting or prognosticating the disease outcome, predicting recurrence following surgery, and monitoring disease progression in an individual having prostate cancer. The methods relate to determining the methylation state of an SLC18A2 gene and/or determining the level of transcription or translation of the gene in a sample from the individual. Methods of treating prostate cancer are also provided. The invention also pertains to compositions and kits for use in the methods.
    Type: Application
    Filed: May 27, 2010
    Publication date: December 2, 2010
    Inventors: KARINA DALSGAARD SØRENSEN, TORBEN FALCK ØRNTOFT, LARS DYRSKJØT ANDERSEN